Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimihide Nakamura

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Hepatology|June 5, 2002
Antithrombin III prevents concanavalin A-induced liver injury through inhibition of macrophage inflammatory protein-2 release and production of prostacyclin in miceKimihide Nakamura, Taku Ito, Masashi Yoneda, et al.
Hepatology (Baltimore, Md.)|September 24, 2004
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitisShiro Yokohama, Masashi Yoneda, Masakazu Haneda, et al.
Biological & Pharmaceutical Bulletin|April 23, 2010
Invariant Valpha14 natural killer T cell activation by edible mushroom acidic glycosphingolipidsHirofumi Nozaki, Saki Itonori, Mutsumi Sugita, et al.
Journal of Nutritional Science and Vitaminology|January 19, 2013
Effects of dietary supplementation with betaine on a nonalcoholic steatohepatitis (NASH) mouse modelSakura Kawakami, Kyu-Ho Han, Yumi Nakamura, et al.
World Journal of Gastroenterology|February 17, 2006
Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitisShiro Yokohama, Yoshihiko Tokusashi, Kimihide Nakamura, et al.
Glycobiology|October 20, 2009
Sialyltransferases of marine bacteria efficiently utilize glycosphingolipid substratesYasunori Kushi, Hisashi Kamimiya, Hiroko Hiratsuka, et al.
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disordersIsao Makino, Kimihide Nakamura, Yoichi Sato, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Hepatology|June 5, 2002
Antithrombin III prevents concanavalin A-induced liver injury through inhibition of macrophage inflammatory protein-2 release and production of prostacyclin in miceKimihide Nakamura, Taku Ito, Masashi Yoneda, et al.
Hepatology (Baltimore, Md.)|September 24, 2004
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitisShiro Yokohama, Masashi Yoneda, Masakazu Haneda, et al.
Biological & Pharmaceutical Bulletin|April 23, 2010
Invariant Valpha14 natural killer T cell activation by edible mushroom acidic glycosphingolipidsHirofumi Nozaki, Saki Itonori, Mutsumi Sugita, et al.
Journal of Nutritional Science and Vitaminology|January 19, 2013
Effects of dietary supplementation with betaine on a nonalcoholic steatohepatitis (NASH) mouse modelSakura Kawakami, Kyu-Ho Han, Yumi Nakamura, et al.
World Journal of Gastroenterology|February 17, 2006
Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitisShiro Yokohama, Yoshihiko Tokusashi, Kimihide Nakamura, et al.
Glycobiology|October 20, 2009
Sialyltransferases of marine bacteria efficiently utilize glycosphingolipid substratesYasunori Kushi, Hisashi Kamimiya, Hiroko Hiratsuka, et al.
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disordersIsao Makino, Kimihide Nakamura, Yoichi Sato, et al.
Pageof 3